CAS 844903-58-8

2-Imidazolidinone,1-[3-[2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl]phenyl]-

Description:

2-Imidazolidinone, 1-[3-[2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl]phenyl]- is a complex organic compound characterized by its imidazolidinone core structure, which features a five-membered ring containing two nitrogen atoms. This compound exhibits a range of functional groups, including a piperazine moiety and a quinoline derivative, contributing to its potential biological activity. The presence of these groups suggests that it may interact with various biological targets, making it of interest in medicinal chemistry. The compound's structure indicates it may possess properties such as lipophilicity and the ability to form hydrogen bonds, which can influence its solubility and permeability. Additionally, the presence of the quinoline ring may impart specific pharmacological properties, as quinolines are known for their diverse biological activities. Overall, this compound's unique structural features suggest potential applications in drug development, particularly in areas related to neuropharmacology or cancer research, although specific biological activities would require further investigation.

Formula: C₂₅H₂₉N₅O

GSK163090

CAS: 844903-58-8

GSK163090

Purity: ≥98%

Molecular weight: 415.53g/mol

Ref: 54-BUP16325

GSK163090

CAS: 844903-58-8

GSK163090 is a specific and orally active 5-HT1A/B/D receptor antagonist (pKis: 9.4/8.5/9.7, and 6.3/6.7 for 5-HT1A/B/D, and dopamine D2/D3).

Formula: C₂₅H₂₉N₅O

Purity: 99.2%

Color and Shape: Solid

Molecular weight: 415.53

Ref: TM-TQ0311

GSK 163090

CAS: 844903-58-8

Antagonist of 5-HT1A/B/D receptors

Formula: C₂₅H₂₉N₅O

Purity: Min. 95%

Molecular weight: 415.53 g/mol

Ref: 3D-FG145140